Literature DB >> 9520386

IPF2alpha-I: an index of lipid peroxidation in humans.

D Praticò1, O P Barry, J A Lawson, M Adiyaman, S W Hwang, S P Khanapure, L Iuliano, J Rokach, G A FitzGerald.   

Abstract

Isoprostanes are prostaglandin isomers produced from arachidonic acid by a free radical-catalyzed mechanism. Urinary excretion of 8-iso-prostaglandin F2alpha, an isomer of the PGG/H synthase (cyclooxygenase or COX) enzyme product, prostaglandin F2alpha (PGF2alpha), has exhibited promise as an index of oxidant stress in vivo. We have developed a quantitative method to measure isoprostane F2alpha-I, (IPF2alpha-I) a class I isomer (8-iso-PGF2alpha is class IV), using gas chromatography/mass spectrometry. IPF2alpha-I is severalfold as abundant in human urine as 8-iso-PGF2alpha, with mean values of 737 +/- 20.6 pg/mg creatinine. Both isoprostanes are formed in a free radical-dependent manner in low density lipoprotein oxidized by copper in vitro. However, IPF2alpha-I, unlike 8-iso-PGF2alpha, is not formed in a COX-dependent manner by platelets activated by thrombin or collagen in vitro. Similarly, COX inhibition in vivo has no effect on IPF2alpha-I. Neither serum IPF2alpha-I, an index of cellular capacity to generate the isoprostane, nor urinary excretion of IPF2alpha-I, an index of actual generation in vivo, is depressed by aspirin or indomethacin. In contrast, both serum thromboxane B2 and urinary excretion of its 11-dehydro metabolite are depressed by the COX inhibitors. Although serum 8-iso-PGF2alpha formation is substantially depressed by COX inhibitors, urinary excretion of the compound is unaffected. Urinary IPF2alpha-I is elevated in cigarette smokers compared with controls (1525 +/- 180 versus 740 +/- 40 pg/mg creatinine; P < 0.01) and is highly correlated with urinary 8-iso-PGF2alpha (r = 0.9; P < 0.001). Urinary IPF2alpha-I is a novel index of lipid peroxidation in vivo, which can be measured with precision and sensitivity. It is an abundant F2-isoprostane formed in a free radical- but not COX-dependent manner. Although 8-iso-PGF2alpha may be formed as a minor product of COX, this pathway contributes trivially, if at all, to levels in urine. Urinary excretion of both isoprostanes is elevated in cigarette smokers.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9520386      PMCID: PMC19856          DOI: 10.1073/pnas.95.7.3449

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Generation of the isoprostane 8-epi-prostaglandin F2alpha in vitro and in vivo via the cyclooxygenases.

Authors:  T Klein; F Reutter; H Schweer; H W Seyberth; R M Nüsing
Journal:  J Pharmacol Exp Ther       Date:  1997-09       Impact factor: 4.030

2.  8-epi PGF2 alpha generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo.

Authors:  N Delanty; M P Reilly; D Pratico; J A Lawson; J F McCarthy; A E Wood; S T Ohnishi; D J Fitzgerald; G A FitzGerald
Journal:  Circulation       Date:  1997-06-03       Impact factor: 29.690

3.  Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes.

Authors:  J Nowak; J J Murray; J A Oates; G A FitzGerald
Journal:  Circulation       Date:  1987-07       Impact factor: 29.690

4.  Enzymatic preparation of carboxyl oxygen-18 labeled prostaglandin F2 alpha and utility for quantitative mass spectrometry.

Authors:  W C Pickett; R C Murphy
Journal:  Anal Biochem       Date:  1981-02       Impact factor: 3.365

5.  Association between cigarette smoking and lipid peroxidation in a controlled feeding study.

Authors:  E R Miller; L J Appel; L Jiang; T H Risby
Journal:  Circulation       Date:  1997-08-19       Impact factor: 29.690

6.  Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  A R Folsom; K K Wu; W D Rosamond; A R Sharrett; L E Chambless
Journal:  Circulation       Date:  1997-08-19       Impact factor: 29.690

7.  11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation.

Authors:  F Catella; D Healy; J A Lawson; G A FitzGerald
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

8.  Evidence that the F2-isoprostane, 8-epi-prostaglandin F2 alpha, is formed in vivo.

Authors:  J D Morrow; T A Minton; K F Badr; L J Roberts
Journal:  Biochim Biophys Acta       Date:  1994-01-03

9.  Cyclooxygenase-dependent formation of the isoprostane, 8-epi prostaglandin F2 alpha.

Authors:  D Pratico; J A Lawson; G A FitzGerald
Journal:  J Biol Chem       Date:  1995-04-28       Impact factor: 5.157

10.  Vitamin E, LDL, and endothelium. Brief oral vitamin supplementation prevents oxidized LDL-mediated vascular injury in vitro.

Authors:  J D Belcher; J Balla; G Balla; D R Jacobs; M Gross; H S Jacob; G M Vercellotti
Journal:  Arterioscler Thromb       Date:  1993-12
View more
  44 in total

Review 1.  Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways.

Authors:  C N Serhan; E Oliw
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

Review 2.  Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension.

Authors:  Marjorie Barrier; Jolyane Meloche; Maria Helena Jacob; Audrey Courboulin; Steeve Provencher; Sébastien Bonnet
Journal:  Cell Mol Life Sci       Date:  2012-03-25       Impact factor: 9.261

3.  Simultaneous HPLC-MS-MS quantification of 8-iso-PGF(2alpha) and 8,12-iso-iPF(2alpha) in CSF and brain tissue samples with on-line cleanup.

Authors:  Magdalena Korecka; Christopher M Clark; Virginia M-Y Lee; John Q Trojanowski; Leslie M Shaw
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-07-01       Impact factor: 3.205

Review 4.  Human biochemistry of the isoprostane pathway.

Authors:  Ginger L Milne; Huiyong Yin; Jason D Morrow
Journal:  J Biol Chem       Date:  2008-02-19       Impact factor: 5.157

5.  Pyridoxamine analogues scavenge lipid-derived gamma-ketoaldehydes and protect against H2O2-mediated cytotoxicity.

Authors:  Sean S Davies; Eric J Brantley; Paul A Voziyan; Venkataraman Amarnath; Irene Zagol-Ikapitte; Olivier Boutaud; Billy G Hudson; John A Oates; L Jackson Roberts
Journal:  Biochemistry       Date:  2006-12-06       Impact factor: 3.162

6.  Eicosapentaenoic-acid-derived isoprostanes: synthesis and discovery of two major isoprostanes.

Authors:  Chih-Tsung Chang; Pranav Patel; Namin Kang; John A Lawson; Wen-Liang Song; William S Powell; Garret A FitzGerald; Joshua Rokach
Journal:  Bioorg Med Chem Lett       Date:  2008-09-06       Impact factor: 2.823

7.  Analysis of F2-isoprostanes in plasma of pregnant women by HPLC-MS/MS using a column packed with core-shell particles.

Authors:  Jessica Larose; Pierre Julien; Jean-François Bilodeau
Journal:  J Lipid Res       Date:  2013-02-21       Impact factor: 5.922

8.  Isoprostanes.

Authors:  L Jackson Roberts; Ginger L Milne
Journal:  J Lipid Res       Date:  2008-10-28       Impact factor: 5.922

9.  Oestrogen metabolites in relation to isoprostanes as a measure of oxidative stress.

Authors:  MaryFran Sowers; Daniel McConnell; Mary L Jannausch; John F Randolph; Robert Brook; Ellen B Gold; Sybil Crawford; Bill Lasley
Journal:  Clin Endocrinol (Oxf)       Date:  2007-11-02       Impact factor: 3.478

Review 10.  Markers of oxidant stress that are clinically relevant in aging and age-related disease.

Authors:  Kimberly D Jacob; Nicole Noren Hooten; Andrzej R Trzeciak; Michele K Evans
Journal:  Mech Ageing Dev       Date:  2013-02-18       Impact factor: 5.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.